Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 8 9 10 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Body Labs–Amazon: investment, 201710 acquisition €na (estimate $50m–$70m) of Body Labs by Amazon 2017-10-03
Cullinan Oncology–F2 Ventures: investment, 201710 financing round Series A totalling $150m incl co-lead investor F2 Ventures 2017-10-03
Cullinan Oncology–SEVERAL: investment, 201710 financing round Series A $150m co-led by UBS Oncology Impact Fund (MPM Capital) + F2 Ventures 2017-10-03
Cullinan Oncology–UBS: investment, 201710 financing round Series A totalling $150m incl co-lead investor UBS Oncology Impact Fund managed by MPM 2017-10-03
Epiontis–Precision Medicine Group: investment, 201709 acquistion of Epiontis GmbH 2017-09-30
Eppendorf–Arburg: plastic moulding machine, 201709 supply of 100th Allrounder machine to Eppendorf Polymere GmbH 2017-09-29
Exscientia–Evotec: investment, 201709 investment €15m by Evotec AG to acquire minority stake in Exscientia Ltd 2017-09-28
Novartis–Univ California: drug discovery technology, 201709– collab establishment of Novartis-Berkeley Center for Proteomics & Chemistry Technologies 2017-09-28
Orgentec–Streck: laboratory equipment, 201709– distribution of Streck cell stabilisation + molecular products by Orgentec SASA in France 2017-09-28
Merlin Diagnostika–Bruker Corp: investment, 201709 acquisition €na by Bruker 2017-09-26
Sonic Healthcare–Bruker Corp: mass spectrometer, 201709 supply existent MLB is long-term user of MALDI Biotyper system 2017-09-26
Atriva Therapeutics–InSynchrony Ventures: investment, 201709 seed financing round 2nd tranche incl new investor InSynchrony Ventures 2017-09-21
Atriva Therapeutics–SEVERAL: investment, 201709 seed financing round 2nd tranche incl new investor InSynchrony Ventures 2017-09-21
Humabs BioMed–Vir Biotechnology: investment, 201709 acquisition of Humabs by Vir 2017-09-21
Juno Therapeutics–Celgene: investment, 201709 private placement $31.1m to Celgene with 758k shares at $41/share 2017-09-20
Juno Therapeutics–SEVERAL: investment, 201709 public offering $250.1m+$37.515m with 6.1m+915k shares at $41/share 2017-09-20
Nabriva–W2O Group: public relations, 201709 service existent PR by Pure Communications 2017-09-20
BioNTech–Akampion: public relations, 201709 service existent by Akampion 2017-09-19
Axiogenesis–Pluriomics: investment, 201709 merger into Ncardia 2017-09-18
Bruker Corp–Bioinformatics Solutions: mass spectrometry software, 201709 collab existent using PEAKS Studio s/w for MS-based proteomics 2017-09-18
Bruker Corp–Max Planck: mass spectrometry, –201709 collab developm of PASEF technology for timsTOF Pro MS for proteomics with Matthias Mann 2017-09-18
High-Tech Gründerfonds–Evonik: investment, 201709 investment existent in HTGF III fund 2017-09-18
Nabriva–SEVERAL: investment, 201709 public offering $80m+$12m with 9.4m+1.4m ordinary shares at $6/share 2017-09-18
Numaferm–Evonik: investment, 201709 Evonik Venture Capital joins €7-digit seed financing round 2017-09-18
ThromboGenics–Novartis: investment, 201709–201801 equity investment €10m by Novartis after termination of Jetrea agreement 2017-09-18
Tolremo Therapeutics–SEVERAL: investment, 201709 seed financing round CHF2.4m 2017-09-18
BioBridges–Adecco: investment, 201709 acquisition €na of BioBridges by Adecco Group 2017-09-14
Evotec–MaRS Innovation: drug discovery, 201709– collab partnership LAB150 for early-stage projects out of Canadian academic institutions 2017-09-14
Ginkgo Bioworks–Bayer: investment, 201709– founding joint venture firm with $100m Series A from Ginkgo + BLSC + Viking Global Investors 2017-09-14
Ginkgo Bioworks–SEVERAL: investment, 201709– founding joint venture with Bayer with $100m Series A from Ginkgo + BLSC + Viking Global Investors 2017-09-14
Ginkgo Bioworks–Viking Global Investors: investment, 201709– founding Ginkgo/Bayer joint venture with $100m Series A from Ginkgo + BLSC + Viking 2017-09-14
Flagship Pioneering–Lipotype: lipid analysis, 201709c supply service lipid anaylsis for Flagship VentureLabs 2017-09-13
Genenta Science–SEVERAL: investment, 201709 financing round Series B €7m 2017-09-13
GreenLight Biosciences–SEVERAL: investment, 201709 financing round Series D $18m led by Fall Line Capital 2017-09-13
Sophia Genetics–SEVERAL: investment, 201709 financing round Series D $30m led by Balderton Capital 2017-09-13
Bayer–Berkeley Lights: cell line development, 201709– collab using Beacon platform for cell line development + antibody discovery 2017-09-12
DNA Script–Idinvest Partners: investment, 201711 financing round Series A totalling €11m incl existing investor Idinvest Partners 2017-09-12
DNA Script–Illumina: investment, 201711 financing round Series A totalling €11m incl lead + new investor Illumina Ventures 2017-09-12
DNA Script–Kurma: investment, 201711 financing round Series A totalling €11m incl existing + seed investor Kurma Partners 2017-09-12
DNA Script–Merck (DE): investment, 201711 financing round Series A totalling €11m incl new investor Merck Ventures BV 2017-09-12
DNA Script–SEVERAL: investment, 201711 financing round Series A €11m led by Illumina Ventuers 2017-09-12
DNA Script–Sofinnova: investment, 201711 financing round Series A totalling €11m incl existing + seed investor Sofinnova Partners 2017-09-12
Ayoxxa–MC Services: public relations, 201709 service existent by MC Services AG 2017-09-11
Epigenomics–Cathay Fortune: credit, 201709 convertible bonds €7.1m net €6.5m to Cathay Fortune 2017-09-08
BRAIN–Hopp Group: investment, 201709 capital increase 1.641m new shares placed with new investor DAH Beteiligungs GmbH 2017-09-07
BRAIN–Hopp Group: investment, 201709 capital increase €28m with 1.641m new shares at €18.055 to new investor DAH Beteiligungs GmbH 2017-09-07
Rigontec–Merck (US): investment, 201709– acquisition €115m cash upfront + €349m milestones 2017-09-06
Amal Therapeutics–BioMedPartners: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor BioMedPartners 2017-09-05
Amal Therapeutics–Boehringer: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor BIVF 2017-09-05
Amal Therapeutics–Helsinn: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor Helsinn Investment Fund 2017-09-05
Amal Therapeutics–High-Tech Gründerfonds: investment, 201709 financing round Series B first closing totalling €8m incl co-investor HTGF 2017-09-05
Amal Therapeutics–Schroders: investment, 201709 financing round Series B first closing totalling €8m incl co-investor Schroder Adveq 2017-09-05
Amal Therapeutics–SEVERAL: investment, 201709 financing round Series B first closing €8m co-led by BIVF + BioMedPartners + Helsinn 2017-09-05
Amal Therapeutics–VI Partners: investment, 201709 financing round Series B first closing totalling €8m incl co-investor VI Partners 2017-09-05
Immunic–SEVERAL: investment, 201709 financing round Series A extension €10m led by LSP bringing total Series A to €31.7m 2017-09-05
Metabolomic Discoveries–Metabolon: investment, 201709 acquisition €na of Metabolomic Discoveries GmbH by Metabolon Inc 2017-09-05
Pharnext–MC Services: public relations, 201709 service existent investor relations Europe by MC Services 2017-09-05
Boehringer–Allcyte: drug discovery, 201709– collab using Pharmacoscopy ex vivo drug response profiling platform for BI oncology candidates 2017-09-04
Amcure–Germany (govt): grant, 201708 BMBF research grant €1.75m to advance clinical lead candidate AMC303 2017-08-31
Angiex–Merck (DE): drug development services, 201708– supply BioReliance End-to-End Solutions for developm of ADC therapy of Angiex Inc 2017-08-29
Apeiron–EU (govt): credit, 201708– EIB EFSI loan €25m to support developm of cancer drugs 2017-08-28
Kite Pharma–Gilead: investment, 201708–201710 acquisition $11.9b cash tender offer $180/share 2017-08-28
Natrix Separations–Merck (DE): investment, 201708– acquisition €na of Natrix Separations by Merck ANNOUNCED 2017-08-28
Aurealis Pharma–SEVERAL: investment, 201708 financing round Series A CHF5.6m from private investors + Finnvera + Tekes 2017-08-25
Novartis–Xoma: IL-1 beta antibodies, 201708– license $26m upfront + $5m investment + milestones + royalties ww rights to gevokizumab + IL-beta Ab IP 2017-08-25
Labfolder–Germany (govt): business development, 201708– supply service support in US with German Accelerator Life Sciences programme 2017-08-24
Macrophage Pharma–Merck (DE): investment, 201708 financing round Series A extension with new investor Merk Ventures 2017-08-23
Batavia–UGA Biopharma: cell line development, –201708 collab devleopm of 2 enzmye expressing monoclonal cell lines for biopharma production 2017-08-22
CRISPR Therapeutics–Partners HealthCare: cell therapy, 201708– collab research + license option 2y w MGHCC develop cancer T cell therapies w CRISPR 2017-08-22
Lilly–Topas Therapeutics: immuno modulatory compounds, 201708– collab €na multi-y research + option agreem 2017-08-22
Micro-Sphere–Ramarketing: public relations, 201708– service by Ramarketing 2017-08-22
AstraZeneca–Ethris: mRNA-based therapeutics, 201708– collab research 5y w €25m upfront + funding + milestones using SNIM®RNA technology 2017-08-21
Ethris–MacDougall Biomedical Communications: public relations, 201708 service existent by MacDougall 2017-08-21
Rodos BioTarget–SEVERAL: investment, 201708 capital increase €800k via crowdfunding platform Aescuvest 2017-08-18
Biotecon–Bruker Corp: mass spectrometer, 201708– distribution OEM of MALDI Biotyper platforms for food analysis in DACH region + Eastern Europe 2017-08-16
Monsanto–ToolGen: CRISPR technology, 201708– license ww €na for use of ToolGen’s CRISPR technology platform in agricultural products 2017-08-16
Roche–Mimetas: organ-on-a-chip technology, –201708 collab developm gut model on-a-chip using OrganoPlate platform 2017-08-16
Purdue Pharma–CellAct: cancer drug, 201708– acquisition ww developm + commerc rights to CAP7.1 by Mundipharma from CellAct 2017-08-14
Roivant–SEVERAL: investment, 201708 financing round $1.1b led by SoftBank Vision Fund + incl Dexxon investor group 2017-08-09
Roivant–SoftBank: investment, 201708 financing round totalling $1.1b incl new + lead investor SoftBank Vision Fund 2017-08-09
Diagnosticum (HU)–Bruker Corp: food analysis, 201708 collab to form Hungarian Wine Consortium using NMR FoodScreener for wine analysis 2017-08-08
IFM Therapeutics–BMS: investment, 201708– acquisition 100% for $300m upfront + up to $2.02b milestones 2017-08-03
Bruker Corp–OTHER: immunoassay technology, 201708 acquisition €na of portable chip-based ELISA platform by Bruker 2017-08-02
Homology Medicines–HBM: investment, 201708 financing round Series B totalling $83.5m incl new + co-investor HBM Healthcare Investments 2017-08-01
Homology Medicines–Novartis: investment, 201708 financing round Series B totalling $83.5m incl new + co-investor Novartis 2017-08-01
Homology Medicines–SEVERAL: investment, 201708 financing round Series B $83.5m led by Deerfield Management 2017-08-01
Lyocontract–Lyomark Pharma: investment, 201708 acquisition of majority share in Lyocontract GmbH by Lyomark Pharma GmbH 2017-08-01
Aptuit–Evotec: investment, 201707–201708 acquisition $300m in cash of Aptuit from Welsh, Carson, Anderson & Stowe 2017-07-30
Evoxx Technologies–Advanced Enzyme Technologies: investment, 201707– acquisition 100% by Advanced Enzymes ANNOUNCED 2017-07-28
Protembis–Germany (govt): grant, 201507 BMBF grant 7-digit € for Protembis in collab with RWTH Aachen 2017-07-28
Evosciences–Danaher: mass spectrometer, 201707– distribution of Sciex MS systems with flexible finacing packages via Evosciences in Europe 2017-07-27
Genkyotex–Alize RP: public relations, 201707 service existent media relations by Alize RP 2017-07-27
Genkyotex–LifeSci: public relations, 201707 service existent in US by LifeSci Advisors 2017-07-27
Genkyotex–NewCap: public relations, 201707 service existent IR by NewCap 2017-07-27
JnJ–Proteros: drug discovery services, 201707– collab €na lead discovery small molecule cancer drugs using NEAT for Jannsen Biotech 2017-07-27
stimOS–Baden-Württemberg (govt): investment, 201707 seed financing round totalling €720k from HTGF + MBG Baden-Württemberg 2017-07-27
stimOS–High-Tech Gründerfonds: investment, 201707 seed financing round totalling €720k from HTGF + MBG Baden-Württemberg 2017-07-27
stimOS–SEVERAL: investment, 201707 seed financing round €720k from HTGF + MBG Baden-Württemberg 2017-07-27
Storm Therapeutics–Evotec: drug discovery services, 201707– supply service expansion €na HTS + structural biology plus chemistry + new targets 2017-07-27
Jazz Pharmaceuticals–XL-protein: PASylation technology, 201707– license $2m upfront + funding + milestones + royalties to develop asparaginase drugs 2017-07-26
next pagenext page 1 2 3 ... 8 9 10 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top